Next Article in Journal
Redo Pelvic Surgery and Combined Metastectomy for Locally Recurrent Rectal Cancer with Known Oligometastatic Disease: A Multicentre Review
Next Article in Special Issue
Topical and Intralesional Immunotherapy for the Management of Skin Cancer in Special Locations: Lips and Eyelids
Previous Article in Journal
MicroRNAs Can Influence Ovarian Cancer Progression by Dysregulating Integrin Activity
 
 
Review
Peer-Review Record

Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review

Cancers 2023, 15(18), 4468; https://doi.org/10.3390/cancers15184468
by Sandra Martínez-Fernández 1,2,*, Beatriz González-Sixto 1,2, Martina Espasandín-Arias 1,2, Diego Soto-García 1,2 and Ángeles Flórez 1,2
Reviewer 1:
Reviewer 2: Anonymous
Cancers 2023, 15(18), 4468; https://doi.org/10.3390/cancers15184468
Submission received: 29 July 2023 / Revised: 2 September 2023 / Accepted: 4 September 2023 / Published: 8 September 2023
(This article belongs to the Special Issue Topical and Intralesional Immunotherapy for Skin Cancer)

Round 1

Reviewer 1 Report

The authors performed a review of the current literature with the aim of investigating the applications of immunotherapy in MIS, either in monotherapy or in combination with other therapeutic alternatives. The manuscript is interesting and well-written. I have only few comments:

- Introduction: nothing to add

- Material and Methods section: this section should be added in order to explain how you performed literature review

- Strengths and limitations: this section should be added

 

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Reviewer 2 Report

This is an excellent review.

One comment:  A description of the types of patients where surgery might not be feasible medically is appropriate (ie the patient with End stage renal disease, Heart Failure etc).  Some of these surgeries can be complex and a lot of people incorrectly think that excision of a superficial lesion is always possible.   

Author Response

Please see the attachment.

Author Response File: Author Response.docx

Back to TopTop